20000-56-0 Usage
Uses
Used in Pharmaceutical Industry:
3-(Benzoxazol-2-yl)benzoic acid is used as a pharmaceutical agent for its potential anti-inflammatory properties. It has been studied for its ability to modulate biological activities, making it a promising candidate for the development of new drugs targeting inflammation-related conditions.
Used in Agrochemical Industry:
In the agrochemical industry, 3-(Benzoxazol-2-yl)benzoic acid is utilized as a key building block in the synthesis of various organic compounds. Its chemical structure and properties make it a valuable component in the development of agrochemical products, such as pesticides and herbicides, contributing to enhanced crop protection and yield.
Used in Organic Synthesis:
3-(Benzoxazol-2-yl)benzoic acid is used as a synthetic building block for the creation of diverse organic compounds. Its unique structure allows for various chemical reactions, facilitating the synthesis of complex molecules with potential applications in various fields, including materials science, pharmaceuticals, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 20000-56-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,0,0 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 20000-56:
(7*2)+(6*0)+(5*0)+(4*0)+(3*0)+(2*5)+(1*6)=30
30 % 10 = 0
So 20000-56-0 is a valid CAS Registry Number.
20000-56-0Relevant academic research and scientific papers
METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
-
, (2011/04/25)
The present invention provides nucleic acid constructs, methods for identifying and validating compounds that increase the inclusion of exon 7 of SMN2 into mRNA transcribed from the SMN2 gene, compounds and pharmaceutical compositions that increase levels of SMN protein produced from the SMN2 gene, and methods for use thereof in treating of SMA.
Novel compounds useful for bradykinin B1 receptor antagonism
-
Page/Page column 55, (2010/11/25)
Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor.
